Non-contrast CT V: See If CT has a Role in Finding Pulmonary Embolism
Official title: Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)
Run by Massachusetts General Hospital · NCT07527117 · Data updated 2026-11-12
This study tests whether additional low-dose, non-contrast CT scans can help detect pulmonary embolism in patients who are already being evaluated for suspected PE.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 750 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Boston, Massachusetts and 1 other locations) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | June 30, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | September 11, 2026 |
| Trial ID | NCT07527117 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 21 years or older undergoing CTPA for suspected acute PE who can consent and meet MMSE criteria (>=18).
✕Probably not a fit
Participants will not personally benefit from the research procedures.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will add two very low-dose CT image acquisitions during a standard evaluation for suspected PE to see if non-contrast imaging can reveal emboli. Participants will blow into a spirometer to practice breath-holding and will be monitored briefly, totaling about 5 minutes of participation. Medical records may be reviewed for 30 to 90 days after the CT scan. The main risks are radiation exposure and minor spirometer-related discomfort.
Why it matters
Potential benefit: If successful, the approach could improve PE detection with minimal additional radiation.
How similar studies have gone: Prior non-contrast CT research in this area is exploratory and its success is not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients undergoing CTPA for suspected aPE 2. Patients who provide written informed consent to participate 3. Adults patients \>/= 21 years of age 4. Mini Mental State Exam (MMSE) score of 18 or more. Exclusion Criteria: 1. Patients who decline informed consent 2. Patients with known chronic PE 3. Patients with known interstitial lung diseases 4. Patients who cannot raise their arms above their shoulders (arms can cause serious artifacts) 5. Women of child-bearing potential (\< 55 years) who test positive for pregnancy test 6. Patients \< 21 years of age (to avoid research radiation dose in young patients) 7. Patients with any EMR documented cognitive impairment or diseases such as dementia, recent head injury, psychiatric disorders, or other neurological diseases that impair decision-making. 8. Pregnant subjects 9. Women of child-bearing potential (21-55 years) who refuse to take a urine pregnancy test prior to their CT examination 10. Mini Mental State Exam (MMSE) score of less than 18.
Where it's running
-
Massachusetts General Hospital/Harvard Medical School
Boston, Massachusetts, United States Recruiting -
Massachusetts General Hospital
Boston, Massachusetts, United States Not yet recruiting
Study contacts
- Study coordinator: Shivangi JHA, MD, MPH
- Email: sjha7@mgh.harvard.edu
- Phone: 16176434583
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Repeated exams to classify early pulmonary embolism
This project will test whether doing repeated blood tests, ECGs, and bedside heart ultrasounds during the first 48 hours after pulmonary embolism helps predict who will get worse in adults treated at Sahlgrenska University Hospital.
-
Best time for reperfusion in acute pulmonary embolism
This study will test whether performing reperfusion (systemic thrombolysis or catheter‑directed therapy) earlier improves survival and reduces complications in adults with high‑risk or intermediate‑high‑risk pulmonary embolism.
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Lung perfusion scans in ED patients with suspected pulmonary embolism
This study looks at how lung perfusion (and sometimes ventilation) scans in adults with suspected pulmonary embolism seen in the emergency department influence clinical decisions and patient outcomes.
-
Thromboelastometry to Predict Thrombosis and Survival in Glial Tumor Surgery
Aimed at people with glial tumors undergoing surgery, the study tests whether thromboelastometry and other blood tests can predict blood-clot risk and survival.
-
Pulsatile Electrical Impedance Tomography to Diagnose and Monitor Acute Pulmonary Embolism
This study tests whether bedside pulsatile electrical impedance tomography can help diagnose and track acute pulmonary embolism without radiation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.